Bond Teva Pharmaceutical Industries 7.125% ( US88167AAN19 ) in USD

Issuer Teva Pharmaceutical Industries
Market price 111.00 %  ▲ 
Country  Israel
ISIN code  US88167AAN19 ( in USD )
Interest rate 7.125% per year ( payment 2 times a year)
Maturity 29/01/2025 - Bond has expired



Prospectus brochure in PDF format

Minimal amount /
Total amount /
Cusip 88167AAN1
Standard & Poor's ( S&P ) rating BB ( Non-investment grade speculative )
Moody's rating Ba2 ( Non-investment grade speculative )
Detailed description Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health.

Teva Pharmaceutical Industries (ISIN: US88167AAN19, CUSIP: 88167AAN1) issued a USD-denominated bond currently trading at 99.133%, offering a 7.125% coupon with semi-annual payments, maturing on January 29, 2025, and rated BB- by S&P and Ba2 by Moody's.
DateClean price
10/01/2025100.03%
12/11/202499.13%
26/09/2024100.13%
18/08/2024100.44%
07/08/2024100.00%
25/06/2024100.44%
10/09/2023100.50%
15/08/2023101.75%
23/07/2023101.75%
29/06/2023101.75%
05/06/2023101.75%
12/05/2023101.75%
19/04/2023101.75%
01/04/2023101.75%
12/03/2023100.75%
18/02/202399.75%
28/01/2023101.38%
06/01/202399.75%
15/12/2022101.50%
23/11/202299.88%
01/11/202299.13%
13/10/202299.13%
25/09/202299.25%
07/09/202299.50%
22/08/2022102.13%
06/08/2022102.13%
22/07/202299.63%
07/07/202297.75%
22/06/202298.13%
08/06/2022101.25%
24/05/2022100.38%
09/05/2022100.13%
24/04/2022103.25%
08/04/2022105.00%
24/03/2022103.50%
09/03/2022103.00%
21/02/2022104.75%
02/02/2022104.88%
18/01/2022106.88%
29/12/2021108.63%
12/12/2021108.00%
25/11/2021107.38%
11/11/2021108.00%
28/10/2021108.00%
14/10/2021109.00%
01/10/2021109.25%
12/09/2021109.25%
28/08/2021109.00%
16/08/2021109.75%
04/08/2021110.50%
23/07/2021109.00%
11/07/2021109.25%
27/06/2021110.00%
13/06/2021111.75%
26/05/2021109.75%
08/05/2021109.00%
18/04/2021111.75%
01/04/2021111.00%